About Richard Knight

Dr Richard Knight PhD, ERT. A co-founder of ApconiX, Richard is an expert toxicologist with more than 20 years of drug development experience gained in AstraZeneca, where he was part of the Drug Safety and Oncology Leadership Teams. Richard has worked on projects in multiple therapy areas involving small molecules, biologics, proteins and oligonucleotides. He has an in-depth understanding of drug discovery and drug development and has been directly involved in bringing over 35 new candidate drugs to clinical trials and 6 to marketing approval. He uses his extensive experience to bring an innovative, science-led and pragmatic approach to the design and delivery of nonclinical safety programmes.

Queen’s Award Celebration

Queen's Award Celebration On Tuesday the 6th of September Lady Redmond, Lord Lieutenant of Cheshire came to Alderley Park to present ApconiX with the Queen’s Award for Enterprise in recognition of excellence in international trade.  Lady Redmond, accompanied by Sir Philip Redmond, presented the certificate to the directors and co-founders Dr Richard Knight, [...]

By |2022-09-28T11:44:16+01:00September 21st, 2022|Company News|Comments Off on Queen’s Award Celebration

Platelet Function Testing in Target Safety Assessments

Platelet Function Testing in Target Safety Assessments Adverse Findings Adverse findings in non-clinical safety/toxicity testing continue to be a major reason for failure and/or complexity in drug projects. Since primary target-related toxicity plays a role in a significant proportion of these failures, an in-depth assessment of potential adverse consequences [...]

By |2022-09-21T12:16:41+01:00September 7th, 2022|Company News, Target Safety Assessments|Comments Off on Platelet Function Testing in Target Safety Assessments

ApconiX is Co-organising a One Day BTS Discovery Toxicology 2022 Event

ApconiX is Co-organising a One Day BTS Discovery Toxicology 2022 Event Dr Nicholas Coltman and Professor Ruth Roberts are co-organising the Science-led Strategies for Success in Discovery & Development Toxicology on Wednesday 15th June 2022 at the Alderley Park Conference Centre in Cheshire.  ApconiX is co-organising the event with [...]

By |2022-09-21T12:28:13+01:00May 17th, 2022|Toxicology, Events|Comments Off on ApconiX is Co-organising a One Day BTS Discovery Toxicology 2022 Event

ApconiX Is Recruiting a Business Development Assistant

ApconiX Is Recruiting a Business Development Assistant The closing date for this job vacancy has passed.  Please visit our Come and Join Us page for current vacancies.  If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to careers@apconix.com ApconiX [...]

By |2022-09-21T12:28:35+01:00May 12th, 2022|Careers|Comments Off on ApconiX Is Recruiting a Business Development Assistant

DDTSS “Paper of the Year” Award Webinar

DDTSS “Paper of the Year” Award Webinar The Drug Discovery Toxicology Specialty Section (DDTSS) DDTSS is hosting a webinar entitled “Species-specific urothelial toxicity with an anti-HIV noncatalytic site integrase inhibitor (NCINI) is related to unusual pH-dependent physicochemical changes" to present the work that was published in Toxicological Sciences and [...]

By |2022-08-22T14:48:21+01:00May 6th, 2022|Toxicology, Events|Comments Off on DDTSS “Paper of the Year” Award Webinar

ApconiX Wins the Queen’s Award for Enterprise

ApconiX Wins the Queen’s Award for Enterprise ApconiX is delighted to be honoured with a Queen’s Award for Enterprise.  Announced today (21st April) ApconiX has been recognised for its excellence in International Trade. ApconiX was founded by Dr Richard Knight, Professor Ruth Roberts and Dr Michael Morton, ex-AstraZeneca colleagues [...]

By |2022-08-22T14:49:36+01:00April 21st, 2022|Company News|Comments Off on ApconiX Wins the Queen’s Award for Enterprise

Professor Ruth Roberts Receives the SOT Drug Discovery Toxicology Specialty Section Paper of the Year Award for 2021

Professor Ruth Roberts Receives the SOT Drug Discovery Toxicology Specialty Section Paper of the Year Award for 2021 The Drug Discovery Toxicology Specialty Section of SOT has selected Professor Ruth Roberts as the recipient of their Paper of the Year Award for 2021. The Paper of the Year Award [...]

By |2022-08-22T14:51:57+01:00March 31st, 2022|Company News, Toxicology|Comments Off on Professor Ruth Roberts Receives the SOT Drug Discovery Toxicology Specialty Section Paper of the Year Award for 2021

Professor Ruth Roberts Is the Mildred S. Christian Career Achievement 2022 Award Recipient

Professor Ruth Roberts Is the Mildred S. Christian Career Achievement 2022 Award Recipient Professor Ruth Roberts received the Academy of Toxicological Sciences’ Mildred S. Christian Career Achievement award for 2022. The Mildred S. Christian Career Achievement Award The Mildred S. Christian Career Achievement Award was established to honour the [...]

By |2022-09-21T12:35:24+01:00March 9th, 2022|Company News, Toxicology|Comments Off on Professor Ruth Roberts Is the Mildred S. Christian Career Achievement 2022 Award Recipient

ApconiX is Delighted to Welcome David Jones

ApconiX Welcomes David Jones ApconiX is delighted to welcome David Jones as a consultant toxicologist after a career spanning over 25 years at the UK Medicines and Healthcare products Regulatory Agency (MHRA).  David is a European Registered Toxicologist and a Fellow of the British Toxicology Society as well as [...]

By |2022-02-21T15:07:23+00:00February 21st, 2022|Toxicology, Careers|Comments Off on ApconiX is Delighted to Welcome David Jones

Professor Ruth Roberts Joins Chair Dr Myrtle Davis at the Drug Safety Gordon Research Conference

Professor Ruth Roberts Joins Chair Dr Myrtle Davis at the Drug Safety Gordon Research Conference Professor Ruth Roberts, Director and Co-founder of ApconiX will be joining Dr Myrtle Davis, Scientific Vice President, Discovery Toxicology, Bristol Myers Squibb as Vice Chair of the at the Gordon Research Conference (GRC) at [...]

By |2022-02-16T13:41:47+00:00February 16th, 2022|Toxicology, Careers, Events|Comments Off on Professor Ruth Roberts Joins Chair Dr Myrtle Davis at the Drug Safety Gordon Research Conference
Go to Top